# Artemis Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/artemis-health

- Industry: Software
- Headquarters: Salt Lake City, US
- Website: www.artemishealth.com
- Total disclosed funding: $48M
- Latest round: Series C (Feb 28, 2019)
- Investors on record: 8

## About

Artemis Health Inc. specializes in benefits analytics software that empowers employers and benefits professionals to make informed healthcare decisions. The innovative solutions streamline reporting and enhance understanding of healthcare costs and employee benefits.Founded in 2013, Artemis Health Inc. is based in Salt Lake City, US. The company focuses on providing analytics tools to help organizations navigate healthcare complexities. The founders, Dallin Regehr and Grant Gordon, have experience in the tech industry, with Grant Gordon currently serving as CEO. Artemis Health has successfully closed 7 funding deals, with the most recent being a Series C round on January 6, 2022, in which they raised USD 22.867 mn led by Bessemer Venture Partners, bringing the total amount raised to USD 22.867 mn. The firm's current valuation is USD 155.889 mn.Artemis Health delivers a suite of benefits analytics software designed to enhance healthcare decision-making for employers and benefits professionals. The core offerings include the Decision Support Tool, which provides insights into Social Determinants of Health, and the Point Solution Evaluator, which assesses the effectiveness of various health programs. Additionally, the Report Automator streamlines financial reporting, while the Full Story Generator identifies cost-saving opportunities through custom reporting. These tools are aimed at helping organizations, including large employers and benefits consultants, navigate the complexities of healthcare costs and employee benefit programs. The solutions are primarily marketed in the United States, targeting a diverse clientele that includes corporate HR departments, benefits brokers, and healthcare plans.Artemis Health's revenue model is based on subscriptions to its analytics platform, facilitating recurring transactions with clients such as employers and benefits consultants. The firm engages clients through annual subscriptions that provide access to its advanced analytics tools, with pricing structures tailored to the specific needs of organizations based on their size and data requirements. Clients benefit from a comprehensive set of tools aimed at enhancing their benefits offerings and improving employee health outcomes. The company’s flagship products, including the Dynamic Cohorts feature and Gaps in Care tools, play a critical role in the delivery of actionable insights that support effective healthcare management strategies. The transaction structure emphasizes a B2B model, focusing on long-term partnerships that enable continuous service enhancement and adaptation to evolving healthcare needs.In January 2022, Nomi Health, Inc. acquired Artemis Health Inc. for USD 200 mn, positioning the company for accelerated growth within Nomi's platform and services. Moving forward, Artemis Health aims to enhance its product offerings and expand into new geographic markets. Specific upcoming products are in development, with launch dates to be announced. The recent funding will be utilized to further support these initiatives, focusing on improving analytics solutions and expanding reach into additional sectors within the healthcare industry.

## Funding rounds

- Series C, Feb 28, 2019, $23M — Bessemer Venture Partners, F-Prime Capital, Kickstart, Hearst Ventures, Maverick Ventures Israel, Rose Park Advisors
- Series B, Aug 16, 2017, $16M — F-Prime Capital, Kickstart, Maverick Ventures Israel
- Series A, Dec 1, 2016, $8.3M — Maverick Ventures Israel
- Seed, Dec 26, 2013, $1.2M — Peterson Partners, Kickstart, Valence Ventures

## Investors

- Peterson Partners (https://capitalatlas.ai/funds/peterson-partners) — Seed
- Kickstart (https://capitalatlas.ai/funds/kickstart) — Seed, Series B, Series C
- Valence Ventures — Seed
- Maverick Ventures Israel (https://capitalatlas.ai/funds/maverick-ventures-israel) — Series A, Series B, Series C
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series B, Series C
- Bessemer Venture Partners (https://capitalatlas.ai/funds/bessemer-venture-partners) — Series C
- Hearst Ventures (https://capitalatlas.ai/funds/hearst-ventures) — Series C
- Rose Park Advisors (https://capitalatlas.ai/funds/rose-park-advisors) — Series C